Market Overview

Stocks Hitting 52-Week Highs

Related SVA
Could Sinovac Biotech Be The Next Ebola Play?
Exclusive: Sinovac IR Director Explains Massive Revenue Opportunity
Related ASBC
UPDATE: Morgan Stanley Reiterates On Associated Banc-Corp As Lower Provision Offsets Remediation Reserve Build
Mercantile Bank (MBWM) in Focus: Stock Tanks 10.7% - Tale of the Tape

Sinovac Biotech (NASDAQ: SVA) shares touched a new 52-week high of $7.60 after the company reported unaudited Q4 results. Sinovac Biotech posted its quarterly net income of $5.8 million, or $0.10 per share, versus a year-ago net loss of $4.6 million, or $0.08 per share.

Associated Banc-Corp (NASDAQ: ASBC) shares rose 1.73% to reach a new 52-week high of $18.20 after the company announced a $120 million buyback plan and shelf registration of $500 million.

On Assignment (NYSE: ASGN) shares gained 4.59% to reach a new 52-week high of $38.54 after Wells Fargo upgraded the stock from Market Perform to Outperform.

The Marcus (NYSE: MCS) rose 6.92% to touch a new 52-week high of $15.60 on Q3 results. Marcus reported its quarterly earnings of $0.15 per share on revenue of $109.80 million.

Posted-In: 52-Week HighsNews Intraday Update Markets Movers

 

Related Articles (ASBC + ASGN)

Around the Web, We're Loving...

Get Benzinga's Newsletters